Gerard Ber

Insider Reports History

Entity
Individual
Location
C/O Y Mabs Therapeutics, Inc., 230 Park Avenue, 33 Rd Floor, New York, NY
Signature
/s/ Eric M. Green, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Gerard Ber:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Lantheus Holdings, Inc. Director Common Stock 21.2K $2.07M $97.78 Aug 12, 2024 Direct
Y-mAbs Therapeutics, Inc. Director Common Stock 1.61K $19.3K $12.00 Jun 10, 2024 Direct
Lantheus Holdings, Inc. Director Stock Option (right to buy) 4.85K May 9, 2024 Direct

Insider Reports Filed by Gerard Ber

Symbol Company Period Transactions Value $ Form Type Date Filed Role
LNTH Lantheus Holdings, Inc. Aug 12, 2024 3 -$1.5M 4 Aug 14, 2024 Director
YMAB Y-mAbs Therapeutics, Inc. Jun 10, 2024 1 -$8.66K 4 Jun 11, 2024 Director
LNTH Lantheus Holdings, Inc. May 9, 2024 2 $0 4 May 13, 2024 Director
YMAB Y-mAbs Therapeutics, Inc. Jun 8, 2023 2 $0 4 Jun 9, 2023 Director
LNTH Lantheus Holdings, Inc. May 11, 2023 2 $0 4 May 15, 2023 Director
LNTH Lantheus Holdings, Inc. May 8, 2023 2 -$54.5K 4 May 15, 2024 Director
YMAB Y-mAbs Therapeutics, Inc. Jul 15, 2022 1 $0 4 Jul 19, 2022 Director
LNTH Lantheus Holdings, Inc. May 10, 2022 1 -$74.3K 4 May 12, 2022 Director
LNTH Lantheus Holdings, Inc. May 6, 2022 1 $0 4/A May 12, 2022 Director
YMAB Y-mAbs Therapeutics, Inc. Jun 10, 2021 1 $0 4 Jun 14, 2021 Director
LNTH Lantheus Holdings, Inc. May 10, 2021 1 $0 4 May 12, 2021 Director